Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL vs ALTEPLASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPROSTADIL vs ALTEPLASE: Safety Overview

Metric ALPROSTADIL ALTEPLASE
Total FAERS Reports 2,800 12,687
Deaths Reported 60 2,540
Death Rate 2.1% 20.0%
Hospitalizations 210 2,083
Average Patient Age 62.5 yrs 62.5 yrs
% Female Patients 4.9% 42.4%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer ENDO USA, Inc. Genentech, Inc.
Route INTRACAVERNOUS INTRAVENOUS
Marketing Status Prescription Prescription